We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

93 hedge funds and large institutions have $203M invested in Cue Health Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more call options, than puts

Call options by funds: $1.77M | Put options by funds: $451K

8% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 26

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

2% less capital invested

Capital invested by funds: $206M → $203M (-$3.59M)

6% less funds holding

Funds holding: 9993 (-6)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
93
Holders Change
-6
Holders Change %
-6.06%
% of All Funds
1.6%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
10
Increased
28
Reduced
26
Closed
16
Calls
$1.77M
Puts
$451K
Net Calls
+$1.32M
Net Calls Change
+$455K
Name Holding Trade Value Shares
Change
Change in
Stake
KI
1
Koch Industries
Kansas
$39.7M
OC
2
Oakmont Corp
California
$28.9M -$690K -194,649 -2%
DCMIC
3
Decheng Capital Management III (Cayman)
Cayman Islands
$27M
BlackRock
4
BlackRock
New York
$19.8M +$4.42M +1,247,012 +23%
JJ
5
Johnson & Johnson
New Jersey
$16.7M
JPC
6
Jabodon PT Co
Nevada
$13.8M
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.2M +$4.71M +1,327,510 +49%
Temasek Holdings
8
Temasek Holdings
Singapore
$9.41M
Geode Capital Management
9
Geode Capital Management
Massachusetts
$5.64M +$3.03M +853,839 +84%
State Street
10
State Street
Massachusetts
$4.97M +$883K +249,009 +18%
BL
11
Bleichroeder LP
New York
$3.01M
Goldman Sachs
12
Goldman Sachs
New York
$2.7M +$117K +32,948 +4%
Northern Trust
13
Northern Trust
Illinois
$2.57M +$513K +144,622 +20%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$1.58M -$438K -123,630 -19%
MP
15
MSD Partners
New York
$1.19M
N
16
Nuveen
North Carolina
$1.16M -$468K -132,045 -26%
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$1.12M +$661K +186,340 +100%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$970K +$104K +29,315 +10%
Charles Schwab
19
Charles Schwab
California
$857K +$169K +47,697 +20%
JP Morgan Chase
20
JP Morgan Chase
New York
$801K +$739K +208,356 +362%
Mirae Asset Global Investments
21
Mirae Asset Global Investments
South Korea
$727K -$155K -43,758 -15%
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$648K +$763K +215,274 New
Renaissance Technologies
23
Renaissance Technologies
New York
$604K +$111K +31,318 +19%
SO
24
STRS Ohio
Ohio
$572K +$149K +41,900 +28%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$486K +$33.6K +9,486 +6%

HLTH Hedge Fund Activity: Q3 2022 in Review

93 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q3 2022, worth a combined $203M — down 1.7% from $206M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of HLTH and 10 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 28 added.

The largest buyer was Vanguard Group, adding an estimated $4.71M. The largest seller was B. Riley Wealth Advisors, cutting an estimated $1.76M.

  • 93 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q3 2022, down from 99 in Q2 2022.
  • Funds reported $203M of Cue Health Inc. Common Stock stock for Q3 2022, down 1.7% quarter-over-quarter.
  • 10 funds opened new Cue Health Inc. Common Stock positions in Q3 2022 and 16 closed out, a net change of -6 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $4.71M added.
  • The largest Cue Health Inc. Common Stock seller in Q3 2022 was B. Riley Wealth Advisors, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2022.